Status: current, Primitive. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4784061000168113 | Olamlo HCT 20/5/12.5 (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4784071000168119 | Olamlo HCT 20/5/12.5 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olamlo HCT 20/5/12.5 | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olamlo HCT 20/5/12.5 tablet, 30 | has TP | True | Olamlo HCT 20/5/12.5 | Inferred relationship | Some | |
| Olamlo HCT 20/5/12.5 tablet | Is a | True | Olamlo HCT 20/5/12.5 | Inferred relationship | Some | |
| Olamlo HCT 20/5/12.5 tablet, 30, blister pack | has TP | True | Olamlo HCT 20/5/12.5 | Inferred relationship | Some | |
| Olamlo HCT 20/5/12.5 tablet, 10 | has TP | True | Olamlo HCT 20/5/12.5 | Inferred relationship | Some | |
| Olamlo HCT 20/5/12.5 tablet, 10, blister pack | has TP | True | Olamlo HCT 20/5/12.5 | Inferred relationship | Some |
Reference Sets
FHIR